Skip to content
Investing

Anthropic IPO Filing Points to a $2 Trillion-Plus Valuation, Lifting European Chipmakers

Anthropic's draft IPO prospectus shows second-quarter revenue of $11.5 billion, and backers expect a valuation above $2 trillion. ASML, Infineon, BESI and ASM International rose as trading opened.

Anthropic staff working at desks and laptops in a sunlit open-plan office, with plants and a sofa in the foreground.
Photo: Anthropic

Anthropic's draft prospectus for a Nasdaq listing shows revenue of $11.5 billion in the second quarter alone, and its backers expect a valuation above $2 trillion, according to a Financial Times report that lifted European chip stocks as trading opened on Tuesday.

The draft S-1 filing was shared with a small group of partners and described to the newspaper by people familiar with it. A Nasdaq listing is expected this autumn. Anthropic has not publicly commented on the reports.

In Europe, the report sent investors back into the companies that supply the hardware behind artificial intelligence. Infineon, BE Semiconductor Industries, ASM International and ASML were among the semiconductor stocks that gained, a day after ASML had fallen 1.2 percent.

Revenue Growth on a Scale Few Companies Have Seen

The numbers in the prospectus show a business growing faster than almost any listed company. Anthropic's 2025 revenue was close to $4.6 billion, about twelve times the year before. Its second-quarter 2026 revenue of $11.5 billion was therefore 2.5 times what it earned in the whole of last year.

The company is on course for a second consecutive quarter of operating profit on an adjusted basis. That is a sharp turn from 2025, when operating expenses of $12.65 billion, more than half of it spent on computing and infrastructure, produced an operating loss of more than $8 billion.

MeasureFigure
Revenue, 2025about $4.6 billion
Operating loss, 2025more than $8 billion
Net loss, 2025about $42 billion
Revenue, Q2 2026$11.5 billion
Cash and short-term investments, end-2025$20.28 billion
Planned cloud, computing and infrastructure obligations$518 billion

The headline net loss of about $42 billion looks alarming but needs reading carefully. Roughly $34 billion of it was an accounting charge linked to financing that could eventually convert into shares, rather than cash spent running the business.

ASML: share price, chart and news

Why a $2 Trillion Price Tag Matters

A valuation above $2 trillion, about €1.73 trillion, would be more than double the $965 billion set in Anthropic's funding round in May. At their peak, pre-IPO contracts traded on the Hyperliquid crypto platform implied a value of around $2.36 trillion.

Set against second-quarter revenue run at an annual pace, a $2 trillion valuation works out at roughly 43 times sales. That is a price that assumes growth continues at a pace few businesses have sustained, and it leaves little margin for disappointment.

The prospectus itself sets out the risks at length. Almost a third of the document is given over to risk factors, including a warning that advanced AI may pose existential risks to humanity. More commercially, close to a quarter of 2025 revenue came from just two customers, and many of the largest clients are not tied to long-term contracts. The company also remains in a dispute with the Pentagon, which has classified it as a supply-chain risk, a decision a federal appeals court upheld last week.

For European investors, the most important figure in the filing may be the $518 billion Anthropic plans to commit to cloud, computing and infrastructure in the coming years. That money flows through cloud providers and chip designers to the companies that make and equip chip factories, where Europe has some of the world's leading suppliers.

ASML makes the lithography machines needed to print the most advanced chips. ASM International supplies equipment that deposits ultra-thin layers on silicon wafers, and BE Semiconductor makes tools for advanced chip packaging, which links processors to high-bandwidth memory. Infineon is a major maker of power chips, including those used in data centres.

An IPO at this valuation would also give Anthropic a large pool of fresh capital to fund those commitments, which helps explain why the report moved equipment makers as much as AI developers.

What Comes Next

The draft is not yet a public filing, and terms such as the size of the offering, the share price range and the listing date have not been set. Investors will be watching for a public S-1, which would allow a full reading of the accounts, the customer concentration and the spending commitments.

For European chip stocks, the deal is a test of whether AI spending can keep growing at its current pace. A successful listing at the expected valuation would support the case. A delay, or a lower price, would raise questions about how much more capital the industry can raise.

Sources

Related stories

Markets

Europe's AI Hardware Stocks Tumble as Nokia Falls 10% After Amodei Urges Slower AI

Nokia fell 10.13%, Infineon 7.72% and ASML 6.13% on 14 September after Anthropic's Dario Amodei urged AI firms to slow frontier model development and the heads of OpenAI and xAI…

Business

ASML Posts Record €11.7bn Quarter and Warns Supply Will Not Meet AI Demand

ASML reported record third-quarter sales of €11.7 billion, guided Q4 to €14.2 to €15.2 billion and said its planned supply for 2027 and 2028 will not fully meet AI-driven demand.

Markets

Nasdaq 100 Sinks 5.5% as Chipmakers Suffer Their Longest Losing Streak Since 2008

The Nasdaq 100 fell 5.49% this week as US chip stocks dropped for eight sessions in a row, the longest run since 2008, on AI spending doubts, $110 Brent and 5% yields. AMD lost…

Markets

Nokia Sinks 10% as AI Chiefs Urge a Slowdown and Volkswagen Flags €10bn of Charges

Nokia fell 10.13% after the heads of Anthropic, OpenAI and xAI urged slower AI development, and Volkswagen cut its margin goal to 1% at most on €10bn of charges. The Euro Stoxx 50…

Investing

Aya Gold & Silver Corrects Q3 Cash Costs to $14.28 an Ounce After Silver Double Count

Aya Gold & Silver refiled its Q3 MD&A after silver in transit was deducted twice. Zgounder ounces sold rise to 1,392,478 and cash costs fall to $14.28 from $15.51. Revenue and…

Investing

FDA Rejects Summit's Lung Cancer Drug Ivonescimab Over Phase 3 Survival Miss

The FDA has rejected Summit Therapeutics' lung cancer drug ivonescimab, saying slower tumour growth in the phase 3 HARMONi trial was not enough without a clear gain in survival.

Investing

Red Cat Withdraws Its $150m to $180m 2026 Revenue Target After $11.8m Third Quarter

Red Cat Holdings has withdrawn its $150m to $180m revenue target for 2026 after third-quarter sales of $11.8m, blaming slower defence funding. Its quarterly net loss more than…

Investing

Berkshire Reveals $689m Bending Spoons Stake, Doubles Lennar and Trims Bank of America Again

Berkshire Hathaway's third-quarter 13F shows a new Bending Spoons stake worth $689m, a doubled Lennar holding and 27.5 million more Bank of America shares sold, while Apple stayed…